Enveric Biosciences, Inc. (ENVB): Operating Cash Flow
-$8.14M
Year ended 2025-12-31
-$8.56M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$8.14M | n/m | 2026-03-27, From 2025-01-01 |
| 2024-12-31 | -$7.73M | n/m | 2026-03-27, From 2024-01-01 |
| 2023-12-31 | -$14.09M | n/m | 2025-03-28, From 2023-01-01 |
| 2022-12-31 | -$17.15M | n/m | 2024-03-26, From 2022-01-01 |
| 2021-12-31 | -$11.46M | n/m | 2023-06-09, From 2021-01-01 |
| 2020-12-31 | -$3.89M | n/m | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | -$647.9K | n/m | 2021-04-01, From 2019-01-01 |
| 2018-12-31 | -$2.57M | n/m | 2020-08-12, From 2018-01-01 |
| 2017-12-31 | -$2.74M | n/m | 2019-03-26, From 2017-01-01 |
| 2016-12-31 | -$2.70M | n/m | 2018-04-02, From 2016-01-01 |
| 2015-12-31 | -$3.90M | n/m | 2017-04-04, From 2015-01-01 |
| 2014-12-31 | -$43.2K | n/m | 2015-03-31, From 2014-01-01 |
| 2013-12-31 | -$21.6K | n/m | 2015-03-31, From 2013-01-01 |
| 2012-12-31 | -$24.9K | n/m | 2014-03-28, From 2012-01-01 |
| 2011-12-31 | -$30.3K | n/m | 2013-02-28, From 2011-01-01 |
| 2010-12-31 | -$40.7K | n/a | 2012-03-07, From 2010-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Enveric Biosciences, Inc. (ENVB) | 2025-12-31 | -$8.14M | n/m |
| Petros Pharmaceuticals, Inc. (PTPI) | 2025-12-31 | -$6.73M | n/m |
| Azitra, Inc. (AZTR) | 2025-12-31 | -$11.22M | n/m |
| Polaryx Therapeutics, Inc. (PLYX) | 2025-12-31 | -$3.94M | n/m |
| Quantum Cyber N.V. (QUCY) | 2025-12-31 | -$10.98M | n/m |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | -$6.85M | n/m |
| International Stem Cell Corp (ISCO) | 2025-12-31 | $8.0K | -38.5% |
| AEON Biopharma, Inc. (AEON) | 2025-12-31 | -$17.31M | n/m |
| Jupiter Neurosciences, Inc. (JUNS) | 2025-12-31 | -$5.41M | n/m |
Compare ENVB, PTPI, AZTR, PLYX side by side · Screen every company in Pharmaceutical Preparations ↗